TIER4

Serial Number 86196139
602

Registration Progress

Application Filed
Feb 18, 2014
Under Examination
Approved for Publication
Published for Opposition
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: TIER4
Previous Owner: TransEngen, Inc.
Classes: 042

Trademark Image

TIER4

Basic Information

Serial Number
86196139
Filing Date
February 18, 2014
Abandonment Date
August 10, 2015
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Sep 5, 2015
Classes
042

Rights Holder

TransEngen, Inc.

03
Address
Suite 210
6 Research Drive
Shelton, CT 06484

Ownership History

TransEngen, Inc.

Original Applicant
03
Shelton, CT

Legal Representation

Attorney
Micheline Johnson

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

14 events
Date Code Type Description Documents
Sep 8, 2015 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Loading...
Sep 5, 2015 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Feb 7, 2015 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Feb 7, 2015 GNRT O NON-FINAL ACTION E-MAILED Loading...
Feb 7, 2015 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 15, 2015 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Loading...
Jan 7, 2015 ALIE A ASSIGNED TO LIE Loading...
May 28, 2014 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
May 28, 2014 GNSL F LETTER OF SUSPENSION E-MAILED Loading...
May 28, 2014 CNSL R SUSPENSION LETTER WRITTEN Loading...
May 25, 2014 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 4, 2014 MPMK E NOTICE OF PSEUDO MARK E-MAILED Loading...
Mar 1, 2014 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 21, 2014 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Software as a service (SAAS) services featuring software for automating or accelerating a medical or pharmacy product's reimbursement process and improving access to medications for patients, providers and other key healthcare stakeholders
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Pseudo Mark
TIER FOUR

Classification

International Classes
042